189 related articles for article (PubMed ID: 36490339)
1. NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification.
Yang Y; Chen C; Zuo Q; Lu H; Salman S; Lyu Y; Huang TY; Wicks EE; Jackson W; Datan E; Wang R; Wang Y; Le N; Zhu Y; Qin W; Semenza GL
Sci Adv; 2022 Dec; 8(49):eabo5000. PubMed ID: 36490339
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness.
Lu H; Xie Y; Tran L; Lan J; Yang Y; Murugan NL; Wang R; Wang YJ; Semenza GL
J Clin Invest; 2020 Sep; 130(9):4607-4623. PubMed ID: 32427586
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
Zhang C; Zhi WI; Lu H; Samanta D; Chen I; Gabrielson E; Semenza GL
Oncotarget; 2016 Oct; 7(40):64527-64542. PubMed ID: 27590511
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.
Lan J; Wei G; Liu J; Yang F; Sun R; Lu H
Theranostics; 2022; 12(6):2598-2612. PubMed ID: 35401817
[No Abstract] [Full Text] [Related]
6. Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment.
Lan J; Lu H; Samanta D; Salman S; Lu Y; Semenza GL
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9640-E9648. PubMed ID: 30242135
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.
Zhang C; Samanta D; Lu H; Bullen JW; Zhang H; Chen I; He X; Semenza GL
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2047-56. PubMed ID: 27001847
[TBL] [Abstract][Full Text] [Related]
8. HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells.
Lu H; Lyu Y; Tran L; Lan J; Xie Y; Yang Y; Murugan NL; Wang YJ; Semenza GL
Cell Rep; 2021 Sep; 36(13):109757. PubMed ID: 34592152
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype.
Xiang L; Gilkes DM; Hu H; Takano N; Luo W; Lu H; Bullen JW; Samanta D; Liang H; Semenza GL
Oncotarget; 2014 Dec; 5(24):12509-27. PubMed ID: 25587023
[TBL] [Abstract][Full Text] [Related]
10. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression.
Luo W; Chang R; Zhong J; Pandey A; Semenza GL
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):E3367-76. PubMed ID: 23129632
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer.
Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
Eur J Cancer; 2013 Jul; 49(11):2608-18. PubMed ID: 23566416
[TBL] [Abstract][Full Text] [Related]
12. Plexin-B3 expression stimulates MET signaling, breast cancer stem cell specification, and lung metastasis.
Zuo Q; Yang Y; Lyu Y; Yang C; Chen C; Salman S; Huang TY; Wicks EE; Jackson W; Datan E; Qin W; Semenza GL
Cell Rep; 2023 Mar; 42(3):112164. PubMed ID: 36857181
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced circSTT3A enhances serine synthesis and promotes H3K4me3 modification to facilitate breast cancer stem cell formation.
Xu M; Liu X; Zhou X; Qin Y; Yang L; Wen S; Qiu Y; Chen S; Tang R; Guo Y; Liu M; Sun Y
Pharmacol Res; 2023 Nov; 197():106964. PubMed ID: 37865128
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment.
Lu H; Tran L; Park Y; Chen I; Lan J; Xie Y; Semenza GL
Cancer Res; 2018 Aug; 78(15):4191-4202. PubMed ID: 29880481
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy.
Xiang L; Semenza GL
Adv Cancer Res; 2019; 141():175-212. PubMed ID: 30691683
[TBL] [Abstract][Full Text] [Related]
16. HIF induces human embryonic stem cell markers in cancer cells.
Mathieu J; Zhang Z; Zhou W; Wang AJ; Heddleston JM; Pinna CM; Hubaud A; Stadler B; Choi M; Bar M; Tewari M; Liu A; Vessella R; Rostomily R; Born D; Horwitz M; Ware C; Blau CA; Cleary MA; Rich JN; Ruohola-Baker H
Cancer Res; 2011 Jul; 71(13):4640-52. PubMed ID: 21712410
[TBL] [Abstract][Full Text] [Related]
17. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
18. HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment.
Nagpal N; Ahmad HM; Chameettachal S; Sundar D; Ghosh S; Kulshreshtha R
Sci Rep; 2015 Apr; 5():9650. PubMed ID: 25867965
[TBL] [Abstract][Full Text] [Related]
19. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
20. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]